Impact of direct-acting antiviral therapy in Egyptian patients with chronic hepatitis C and liver cirrhosis

Assessment of Haematological and Immunological Effect after New Direct ‎Acting Antiviral Drugs in Chronic Hepatitis C Virus Egyptian Patients

TYPES AND PREDICTORS OF INTERFERON/RIBAVIRIN INDUCED CARDIAC COMPLICATIONS IN THE EGYPTIAN PATIENTS WITH CHRONIC HEPATITIS C VIRUS

SAFETY AND EFFICACY OF DIRECTLY ACTING ANTIVIRAL DRUGS IN TREATMENT OF CHRONIC HCV EGYPTIAN PATIENTS

Assessment of Degree of Fibrosis in Chronic Hepatitis C Virus Patients Treated with Direct Acting Antiviral Agents

Assessment of Coronary Artery Disease Severity in Hepatitis C Patients at Suez Canal University Hospital Cardiac Catheterization Laboratory

Effect of Treatment With Direct Acting Antivirals on Glucose and Lipid Metabolism in Egyptian Patients With Chronic Hepatitis C

Impact of long-term eradication of chronic Hepatitis C infection using the direct-acting antiviral treatment on liver fibrosis parameters in Egyptian patients

Impact of Direct-Acting Antiviral Agents Treatment on Body Mass Index and Lipid Profile in Egyptian Chronic Hepatitis C Patients

Effect of Direct-Acting Antiviral Therapy on Lipid Profile in Egyptian Patients with Chronic Hepatitis C Infection